%0 Journal Article %T Biomarkers for the prediction of oncologic outcomes in nonmuscle invasive bladder cancer: state of affairs and new frontiers %A Soria, Francesco %A Shariat, Shahrokh F. %J Translational Andrology and Urology %D 2018 %B 2018 %9 %! Biomarkers for the prediction of oncologic outcomes in nonmuscle invasive bladder cancer: state of affairs and new frontiers %K %X Non-muscle invasive bladder cancer (NMIBC) represents approximately 75% of newly diagnosed bladder cancers (BCa) in western countries (1). Patients with NMIBC have a relatively favorable prognosis, with ten-years cancer-specific survival (CSS) rates varying between 75% and 100%, depending on tumor grade (2). %U https://tau.amegroups.org/article/view/20905 %P S753-S755 %@ 2223-4691